BRCA2 is highly expressed in prostate cancer tissues, and silencing of this gene can block the activation of the ATM signaling pathway, thereby inhibiting the proliferation of prostate cancer cells and promoting their apoptosis.[39] In addition, it has been suggested that BRCA mutations are not associated with prostate cancer development. The gene discussed is BRCA2; the disease is prostate carcinoma.